Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PRKG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNRD1ASP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FKBP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130992 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCRL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AWAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507547 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MST1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EHD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF793 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC16A10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LACE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAH9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NHS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on